Literature DB >> 29434385

Antibiotics in Development for the Treatment of Resistant Bacterial Disease.

Ryan Kidd1, Scot Walker2.   

Abstract

Many bacterial infections can be treated with the use of antibiotics. These medications continue to reduce morbidity and mortality; unfortunately, their use has brought about drug-resistant pathogens that produce difficult-to-treat infections, which require more extreme treatments. New antibiotics are needed to combat this ever-evolving resistance pathogenesis.

Entities:  

Keywords:  formulary management/P&T; infectious diseases; investigational drugs

Year:  2017        PMID: 29434385      PMCID: PMC5805018          DOI: 10.1177/0018578717741393

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  4 in total

1.  General principles of antimicrobial therapy.

Authors:  Surbhi Leekha; Christine L Terrell; Randall S Edson
Journal:  Mayo Clin Proc       Date:  2011-02       Impact factor: 7.616

Review 2.  Treatment options for multidrug-resistant bacteria.

Authors:  Helen Giamarellou
Journal:  Expert Rev Anti Infect Ther       Date:  2006-08       Impact factor: 5.091

Review 3.  Epidemiology and prevention of bacterial infections in patients with hematologic malignancies.

Authors:  Jeffrey Tessier; Costi D Sifri
Journal:  Infect Disord Drug Targets       Date:  2011-02

4.  Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.

Authors:  Thomas J Dilworth; Jora Sliwinski; Keenan Ryan; Monique Dodd; Renée-Claude Mercier
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.